Search

everythinglearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

The dietary supplement helped increase hair growth in women with hair loss.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

PRP therapy helps skin heal and improve by promoting cell growth and repair.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

GI197111X is best dissolved in Capmul MCM for trials.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

A man with alopecia universalis regrew hair temporarily after a bone treatment.

The new silicone gel wound dressing may speed up early healing after hair transplant surgery compared to Bacitracin.

Thymosin β4 helps improve skin healing and reduce scarring.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Some alopecia treatments might help treat COVID-19, but more research is needed.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Thiosulfate may help hair grow faster in mice and works well with a common hair growth treatment.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Brodalumab is more effective than ustekinumab for treating psoriasis.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Dutasteride is more effective than finasteride for hair growth with similar side effects.